STOCK TITAN

[Form 4] INTERNATIONAL ISOTOPES INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

International Isotopes Inc. (INIS) director reported an equity grant. On 10/10/2025, the insider acquired 250,000 shares of common stock at $0, recorded as a grant of restricted stock units, with each unit representing the right to receive one INIS share. Following the transaction, the insider beneficially owned 1,000,000 shares, held directly.

International Isotopes Inc. (INIS) un dirigente di International Isotopes Inc. (INIS) ha riportato una concessione azionaria. Il 10/10/2025, l'insider ha acquisito 250.000 azioni ordinarie a $0, registrata come assegnazione di unità vincolate di azioni, ciascuna unità conferisce il diritto a ricevere una azione INIS. Dopo la transazione, l'insider possedeva beneficiariamente 1.000.000 azioni, detenute direttamente.

International Isotopes Inc. (INIS) director informó una concesión de acciones. El 10/10/2025, el insider adquirió 250,000 acciones de acciones comunes a $0, registrada como una asignación de unidades de acciones restringidas, cada unidad representa el derecho a recibir una acción INIS. Tras la transacción, el insider poseía beneficiosamente 1,000,000 acciones, mantenidas directamente.

International Isotopes Inc. (INIS) 이사가 주식 보상 부여를 보고했습니다. 2025년 10월 10일, 내부자는 250,000주의 보통주를 $0에 취득했고, 이는 각 유닛이 INIS 주식 한 주를 받을 권리를 나타내는 제한된 주식 단위(RSU)의 부여로 기록되었습니다. 거래 후 내부자는 1,000,000주를 직접 보유했습니다.

International Isotopes Inc. (INIS) a annoncé une attribution d’actions par un administrateur. Le 10/10/2025, l’insider a acquis 250 000 actions ordinaires à 0 $, enregistrée comme une attribution d’unités d’actions restreintes, chaque unité donnant le droit de recevoir une action INIS. Suite à la transaction, l’insider détenait bénéficiairement 1 000 000 d’actions, détenues directement.

International Isotopes Inc. (INIS) Director meldete eine Aktienzuteilung. Am 10.10.2025 erwarb der Insider 250.000 Aktien der Stammaktien zu $0, registriert als Zuteilung von Restricted Stock Units (RSU), wobei jede Einheit das Recht auf den Erhalt einer INIS-Aktie repräsentiert. Nach der Transaktion besaß der Insider wirtschaftlich 1.000.000 Aktien, direkt gehalten.

International Isotopes Inc. (INIS) أبلغ مدير عن منحة أسهم. في 10/10/2025، اشترى المطلع 250,000 سهم من الأسهم العادية بسعر $0، مُسجَّلة كمنحة وحدات أسهم مقيدة، مع كل وحدة تمثل حق الحصول على سهم INIS واحد. عقب الصفقة، أصبح لدى المطلع ملكياً فائدة 1,000,000 سهم، ويُحتفظ بها مباشرةً.

International Isotopes Inc. (INIS) 董事报告了股票授予。2025/10/10,内部人士以0美元购买了250,000股普通股,被记录为受限股票单位的授予,每单位代表获得一股 INIS 股票的权利。交易完成后,该内幕人士实际持有1,000,000股,直接持有。

Positive
  • None.
Negative
  • None.

International Isotopes Inc. (INIS) un dirigente di International Isotopes Inc. (INIS) ha riportato una concessione azionaria. Il 10/10/2025, l'insider ha acquisito 250.000 azioni ordinarie a $0, registrata come assegnazione di unità vincolate di azioni, ciascuna unità conferisce il diritto a ricevere una azione INIS. Dopo la transazione, l'insider possedeva beneficiariamente 1.000.000 azioni, detenute direttamente.

International Isotopes Inc. (INIS) director informó una concesión de acciones. El 10/10/2025, el insider adquirió 250,000 acciones de acciones comunes a $0, registrada como una asignación de unidades de acciones restringidas, cada unidad representa el derecho a recibir una acción INIS. Tras la transacción, el insider poseía beneficiosamente 1,000,000 acciones, mantenidas directamente.

International Isotopes Inc. (INIS) 이사가 주식 보상 부여를 보고했습니다. 2025년 10월 10일, 내부자는 250,000주의 보통주를 $0에 취득했고, 이는 각 유닛이 INIS 주식 한 주를 받을 권리를 나타내는 제한된 주식 단위(RSU)의 부여로 기록되었습니다. 거래 후 내부자는 1,000,000주를 직접 보유했습니다.

International Isotopes Inc. (INIS) a annoncé une attribution d’actions par un administrateur. Le 10/10/2025, l’insider a acquis 250 000 actions ordinaires à 0 $, enregistrée comme une attribution d’unités d’actions restreintes, chaque unité donnant le droit de recevoir une action INIS. Suite à la transaction, l’insider détenait bénéficiairement 1 000 000 d’actions, détenues directement.

International Isotopes Inc. (INIS) Director meldete eine Aktienzuteilung. Am 10.10.2025 erwarb der Insider 250.000 Aktien der Stammaktien zu $0, registriert als Zuteilung von Restricted Stock Units (RSU), wobei jede Einheit das Recht auf den Erhalt einer INIS-Aktie repräsentiert. Nach der Transaktion besaß der Insider wirtschaftlich 1.000.000 Aktien, direkt gehalten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Atcher Robert

(Last) (First) (Middle)
4137 COMMERCE CIRCLE

(Street)
IDAHO FALLS ID 83401

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INTERNATIONAL ISOTOPES INC [ INIS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/10/2025 A 250,000(1) A $0 1,000,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reporting person was granted restricted stock units, with each restricted stock unit representing a contingent right to receive one share of INIS common stock.
/s/ Shahe Bagerdjian, Attorney-in-fact 10/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did INIS report in this Form 4?

A director acquired 250,000 shares of INIS common stock at $0 on 10/10/2025 via a grant of restricted stock units.

How many INIS shares does the insider own after the transaction?

The filing lists 1,000,000 shares beneficially owned following the reported transaction.

What was the ownership form after the transaction?

The shares were reported as held Direct (D).

What is the nature of the 250,000-share grant?

It is a grant of restricted stock units, each representing a contingent right to receive one INIS common share.

What was the transaction price for the acquired shares?

The filing shows a price of $0 for the acquired 250,000 shares.

What is the date of the earliest transaction reported?

The earliest transaction date disclosed is 10/10/2025.
International Isotopes

OTC:INIS

INIS Rankings

INIS Latest News

INIS Latest SEC Filings

INIS Stock Data

31.69M
141.35M
73.24%
0%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Idaho Falls